Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Emmanuel Doulain

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Dalton Transactions (Cambridge, England : 2003)|May 5, 2016
Development of trackable metal-based drugs: new generation of therapeutic agentsBenoît Bertrand, Pierre-Emmanuel Doulain, Christine Goze, et al.
Chemical Communications (Cambridge, England)|March 2, 2016
BODIPY atropisomer interconversion, face discrimination, and superstructure appendingPierre-Emmanuel Doulain, Christine Goze, Ewen Bodio, et al.
Analytical Chemistry|October 18, 2012
Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studiesFlorian Lafaille, Bernard Banaigs, Nicolas Inguimbert, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 2, 2013
Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography-tandem mass spectrometryFlorian Lafaille, Isabelle Solassol, Christine Enjalbal, et al.
Dalton Transactions (Cambridge, England : 2003)|December 11, 2014
Towards the elaboration of new gold-based optical theranosticsPierre-Emmanuel Doulain, Richard Decréau, Cindy Racoeur, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|December 6, 2014
Gold-phosphine-porphyrin as potential metal-based theranosticsSemra Tasan, Cynthia Licona, Pierre-Emmanuel Doulain, et al.
Pharmaceutics|November 11, 2022
Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic HyperthermiaAlexandre M M Dias, Alan Courteau, Pierre-Simon Bellaye, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Dalton Transactions (Cambridge, England : 2003)|May 5, 2016
Development of trackable metal-based drugs: new generation of therapeutic agentsBenoît Bertrand, Pierre-Emmanuel Doulain, Christine Goze, et al.
Chemical Communications (Cambridge, England)|March 2, 2016
BODIPY atropisomer interconversion, face discrimination, and superstructure appendingPierre-Emmanuel Doulain, Christine Goze, Ewen Bodio, et al.
Analytical Chemistry|October 18, 2012
Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studiesFlorian Lafaille, Bernard Banaigs, Nicolas Inguimbert, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 2, 2013
Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography-tandem mass spectrometryFlorian Lafaille, Isabelle Solassol, Christine Enjalbal, et al.
Dalton Transactions (Cambridge, England : 2003)|December 11, 2014
Towards the elaboration of new gold-based optical theranosticsPierre-Emmanuel Doulain, Richard Decréau, Cindy Racoeur, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|December 6, 2014
Gold-phosphine-porphyrin as potential metal-based theranosticsSemra Tasan, Cynthia Licona, Pierre-Emmanuel Doulain, et al.
Pharmaceutics|November 11, 2022
Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic HyperthermiaAlexandre M M Dias, Alan Courteau, Pierre-Simon Bellaye, et al.
Pageof 1